Daihan Pharmaceutical Co.,Ltd. (KOSDAQ:023910)
South Korea · Delayed Price · Currency is KRW 25,300
-100 (-0.39%)
Oct 23, 2026, 3:30 PM KST
Daihan Pharmaceutical Market Cap
Daihan Pharmaceutical has a market cap or net worth of 148.76 billion as of October 23, 2026. It is the 24,305th most valuable company in the world and the 997th biggest in South Korea. Its market cap has decreased by 14.81% in one year.
Market Cap
148.76B
Enterprise Value
34.07B
Revenue
216.55B
Global Rank
Country Rank
#997 South Korea
PE Ratio
5.40
ChartMarket Cap Chart
Since March 1, 2001, Daihan Pharmaceutical's market cap has increased from 22.26B to 148.76B, an increase of 568.30%. That is a compound annual growth rate of 7.68%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 23, 2026 | 148.76B | -13.50% |
| Dec 30, 2025 | 171.99B | 11.64% |
| Dec 30, 2024 | 154.06B | -5.59% |
| Dec 28, 2023 | 163.17B | -11.13% |
| Dec 29, 2022 | 183.60B | 6.62% |
| Dec 30, 2021 | 172.20B | -12.90% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| REYON Pharmaceutical | 181.94B |
| Samil Pharmaceutical Co.,Ltd | 176.09B |
| Chong Kun Dang Holdings | 169.95B |
| Daewon Pharmaceutical | 167.18B |
| JW Lifescience | 163.83B |
| Ilsung Is | 152.62B |
| Dongwha Pharm.Co.,Ltd | 149.68B |
| Hana Pharm | 148.94B |